Rhodamine 123 phototoxicity in laser-irradiated MGH-U1 human carcinoma cells studied in vitro by electron microscopy and confocal laser scanning microscopy.
Rhodamine 123 (R123) is a permeant, cationic, fluorescent dye that localizes preferentially within mitochondria of living carcinoma cells. MGH-U1 human bladder carcinoma cells incubated in vitro with 10 microM R123 for 30 min and then irradiated at 514.5 nm with an argon ion laser underwent selective, phototoxic injury to mitochondria. Ultrastructurally, treatment with R123 plus irradiation with 10 J/cm2 caused selective, progressive mitochondrial alterations consisting of disruption of cristae, vacuolization, swelling, increasing numbers of ring-shaped and angulated mitochondria at 4 to 8 h after irradiation, and obliteration of many mitochondria at 24 to 48 h. Confocal laser scanning microscopy after treatment with R123 plus irradiation with 10 to 30 J/cm2 demonstrated altered uptake and localization of subsequently administered R123, accompanied by striking mitochondrial fragmentation. Irradiation caused a dose-dependent depletion of extractable R123, due to a photosensitized efflux that began immediately and progressed by 4 h after irradiation with 10 to 30 J/cm2; further uptake after reincubation in the presence of R123 was also quantitatively impaired in cells previously irradiated with 30 J/cm2.
Shea
C R
CR
Wellman Laboratories of Photomedicine, Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston 02114.
Sherwood
M E
ME
Flotte
T J
TJ
Chen
N
N
Scholz
M
M
Hasan
T
T
D002295:Carcinoma, Transitional Cell / Q000032:analysis / Q000628:therapy* / Q000648:ultrastructure; D006801:Humans; D053685:Laser Therapy; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning / Q000379:methods; D008928:Mitochondria / Q000187:drug effects / Q000528:radiation effects; D010789:Phototherapy; D020112:Rhodamine 123; D012235:Rhodamines / Q000032:analysis / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured; D001749:Urinary Bladder Neoplasms / Q000032:analysis / Q000628:therapy* / Q000648:ultrastructure; D014966:Xanthenes / Q000627:therapeutic use*
D012235:Rhodamines; D014966:Xanthenes; D020112:Rhodamine 123